Severity of Covid-19 infection among kidney transplant recipients in Duhok city, Kurdistan region, Iraq


  • Zana Sidiq Mohammed Saleem Department of Internal Medicine, College of Medicine, University of Duhok, Duhok, Iraq.



Organ Transplants, COVID-19, Duhok, Iraq


Objectives: Kidney transplant recipients are risky group population in whom greater morbidity and mortality reported in comparison to general population.

Methods: We examined a prospectively cohort of 80 SOT Kidney transplant recipients with first-wave COVID-19, participants assessed and grouped into severe and non-severe illness.

Results: Eighty kidney transplant recipients involved in our study, with average age of 46.6 ± 12.2 years and kidney transplant duration of 6.4 ± 3.5 years. Fifty four were male (67.5%). Comorbidities included hypertension (60%), diabetes mellitus (18.8), coronary heart disease (3.8), and hypothyroidisim (2.5). Twelve patients had severe Covid-19 infection (15%) and sixty eight with non-severe (85%).

Risk factors for severe COVID-19 infection in this study were male gender, old age, comorbidities, obesity, longer duration of COVID-19 symptoms, kidney transplantation duration, C-reactive protein > 24 mg/L, Interlukine-6 > 26pg/mL and D-Dimer level> 1000ng/mL Modulation of immunosuppressive drugs done only for  severe cases Eight transplant recipients needed admission to hospital and one necessitate mechanical ventilation.

Conclusion: Kidney transplant recipients are at high risk of acquiring opportunistic infections including COVID-19 infection. The most important strategy in kidney transplant recipients to prevent COVID-19 infection is through adopting preventive measures in particular the use of masks and avoidance of crowded non-ventilated places. Risk stratification and poor outcome factor is crucial strategy to prevent spread of the infection.


Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727–733.

Burke RM, Killerby ME, Newton S et al. Symptom profiles of a convenience sample of patients with COVID-19 – United States. MMWR Morb Mortal Wkly Rep 2020; 69: 904–908.

Ferna´ndez-Ruiz M, Aguado JM. Immunomodulatory therapies for COVID-19 in solid organ transplant recipients. Curr Transplant Rep 2020. doi: 10.1007/s40472-020-00306-x.

Craig-Schapiro R, Salinas T, Lubetzky M et al. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am J Transplant 2020; doi: 10.1111/ajt.16351.

Pei G, Zhang Z, Peng J et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 2020; 31: 1157–1165.

Hirsch JS, Ng JH, Ross DW et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020; 98: 209–218.

Fisher M, Neugarten J, Bellin E et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol 2020; 31: 2145–2157.

Kates OS, Haydel BM, Florman SS et al. COVID-19 in solid organ transplant: a multi-center cohort study. Clin Infect Dis 2020; doi: 10.1093/cid/ciaa1097.

Miarons M, Larrosa-Garcı´a M, Garcı´a-Garcı´a S et al.COVID19 in solid organ transplantation: a matched retrospective cohort study and evaluation of immunosuppression management. Transplantation 2021; 105: 138–150.

Alberici F, Delbarba E, Manenti C et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int 2020; 97: 1083–1088.

Coll E, Ferna´ndez-Ruiz M, Sa´nchez-A´ lvarez JE et al. COVID19 in transplant recipients: the Spanish experience. Am J Transplant; doi: 10.1111/ajt.16369.

Cravedi P, Suraj SM, Azzi Y et al. COVID-19 and kidney transplantation: results from the TANGO international transplant consortium. Am J Transplant 2020; 20: 3140–3148.

Fava` A, Cucchiari D, Montero N et al. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: a multicentric cohort study. Am J Transplant 2020; 20: 3030–3041.

Cavalcanti AB, Zampieri FG, Rosa RG et al. Hydroxychloroquine with or without azithromycin in mildto-moderate Covid-19. N Engl J Med 2020; 383: 2041–2052.

Chaudhry ZS, Williams JD, Vahia A et al. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: a case-control study. Am J Transplant 2020; 20: 3051–3060.

Williamson E, Walker AJ, Bhaskaran K et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv 2020; doi: 10.1101/2020.05.06.20092999.

Mahalingasivam V, Craik A, Tomlinson LA et al. COVID-19 and kidney transplantation: a systematic review. Kidney Int Rep 2020; 6: 24–45.

Guan W-J, Ni Z-Y, Hu YU, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.

Wang D, Hu BO, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. https://

Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. Published online April 17, 2020:NEJMc2010419.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–62. pmid:32171076.

Kute VB, Bhalla AK, Guleria S, Ray DS, Bahadur MM, Shingare A, et al. Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: a Multicenter Cohort Study From India. Transplantation. 2020 Dec 21. pmid:33350674.

Yi SG, Rogers AW, Saharia A, Aoun M, Faour R, Abdelrahim M, et al. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center. Transplantation. 2020 Jun.

Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, van Kampen JAA, et al. Covid-19 in solid organ transplant recipients: A single center experience. Transpl Int. 2020 May. pmid:32460390.

Mohamed IH, Chowdary PB, Shetty S, Sammartino C, Sivaprakasam R, Lindsey B, et al. Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients. Transplantation. 2021 Jan 1;105(1):115–120. pmid:33350626.

Aslam S, Mehra MR. COVID-19: yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020;39(5):408–9. 0.1016/j.healun.2020.03.007.

A, Mascolo S. Immunosuppression drug-related and clinical manifestation of coronavirus disease 2019: a therapeutical hypothesis. Am J Transplant. 2020;20(7):1947–8.

Kuczmarski RJ, Carrol MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542- 548.

(COVID-19 Treatment Guidelines on 6/12/2021).

Jonathan A C Sterne , Srinivas Murthy et al. Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-analysis. JAMA 2020 Oct 6;324(13):1330-134.

Fernández-Ruiz M, Andrés A, Loinaz C, Delgado JF, López-Medrano F, San Juan R, et al: COVID-19 in solid organ transplant recipients: A single-center case series from Spain. Am J Transplant 20: 1849–1858, 2020.

Rupesh Raina , Zubin A Mahajan, Prabhav Vasistha. Incidence and Outcomes of Acute Kidney Injury in COVID-19: A Systematic Review. Blood Purif 2021 Jun 15;1-14.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054–62.

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis (Berl). 2020;7(2):91–6.

Ahmed Daoud , Ahmad Alqassieh , Duaa Alkhader , Maria Aurora Posadas Salas , Vinaya Rao , Tibor Fülöp , Karim M Soliman . Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading. Ren Fail 2021 Dec;43(1):273-280.

Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of Two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020 383(25):2439–50.

Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and immunogenicity of SARS-CoV-2 mRNA1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427–38.




How to Cite

Saleem, Z. S. M. . (2022). Severity of Covid-19 infection among kidney transplant recipients in Duhok city, Kurdistan region, Iraq. Journal of Contemporary Medical Sciences, 8(1), 75–78.